The Fund Grade · free · no account needed
What grade does FSLSX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Fidelity Value Strategies Fund
#216 of 500 graded active funds · value · mid segment peer group
The point · specialist footprint
FSLSX puts less of its book behind proven specialists than 77% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
FSLSX vs the Honor Roll · share card ↗Conviction exposure
6.7%
of the book in specialist-converged names
Late-stage weight
26.3%
of the book in Crowded or Fading names
Active share
93.1%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Fidelity Value Strategies earns a B grade and ranks 216 of 500, with only 6.7% specialist ownership suggesting limited high-conviction backing. Five positions including PCG, WFRD, APO, and FSLR show specialists actively leaving, while IRM and PACS represent the fund's clearest early-stage opportunities. Higher-graded funds exist within Fidelity's own lineup.
→ Monitor the combined fading weight in PCG, WFRD, APO, and FSLR, totaling roughly 3.7% of the fund, as specialist exits could pressure those names.
→ Track IRM and PACS, the fund's two strongest early-stage positions, to judge whether the B grade improves if those ideas gain broader specialist recognition.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.